Cargando…
The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) remains a very challenging malignancy with late presentation, metastatic potential, chemoresistance, and poor prognosis. Therefore, there is an urgent need for novel diagnostic and prognostic biomarkers. miRNAs are small noncoding RNAs that regulate the expres...
Autores principales: | Ren, Le, Yu, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790163/ https://www.ncbi.nlm.nih.gov/pubmed/29416345 http://dx.doi.org/10.2147/TCRM.S154226 |
Ejemplares similares
-
Fibrosis-related miRNAs as serum biomarkers for pancreatic ductal adenocarcinoma
por: Suzuki, Rei, et al.
Publicado: (2017) -
MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy
por: Song, Yongan, et al.
Publicado: (2023) -
Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma
por: Hu, Xiu, et al.
Publicado: (2021) -
Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma
por: Khan, Imteyaz Ahmad, et al.
Publicado: (2021) -
Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma
por: Dobre, Maria, et al.
Publicado: (2021)